Jefferies Financial Group’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.06M Buy
9,896
+6,396
+183% +$774K 0.01% 945
2026
Q1
$572K Sell
3,500
-922,839
-100% -$142M ﹤0.01% 1152
2025
Q4
$161M Buy
926,339
+818,242
+757% +$149M 0.82% 16
2025
Q3
$15.6M Buy
108,097
+103,114
+2,069% +$12.6M 0.07% 170
2025
Q2
$501K Buy
4,983
+2,483
+99% +$190K ﹤0.01% 905
2025
Q1
$191K Sell
2,500
-2,500
-50% -$191K ﹤0.01% 1399
2024
Q4
$345K Buy
5,000
+4,507
+914% +$325K ﹤0.01% 1220
2024
Q3
$36K Sell
493
-26,207
-98% -$1.93M ﹤0.01% 1355
2024
Q2
$1.79M Buy
26,700
+19,111
+252% +$741K 0.02% 568
2024
Q1
$206K Buy
7,589
+7,039
+1,280% +$197K ﹤0.01% 1335
2023
Q4
$17K Sell
550
-2,290
-81% -$59.4K ﹤0.01% 1616
2023
Q3
$71.7K Buy
+2,840
New +$65K ﹤0.01% 1487
2023
Q2
Sell
-65,900
Closed -$1.12M 1841
2023
Q1
$1.12M Buy
+65,900
New +$1.28M 0.01% 855

Other funds holding INSM

Jefferies Financial Group's INSM Position: Q2 2026 in Review

Jefferies Financial Group increased its Insmed (INSM) stake by 183% in Q2 2026, buying an estimated $774K and bringing the position to 9,896 shares worth $1.06M. The position accounts for 0.01% of the portfolio, ranked #945.

Jefferies Financial Group first reported a position in INSM in Q1 2023 and has held it in 13 quarters since. The position peaked at $161M in Q4 2025. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Jefferies Financial Group held 9,896 shares of Insmed worth $1.06M as of Q2 2026.
  • Jefferies Financial Group bought 6,396 Insmed shares in Q2 2026, an estimated $774K.
  • Insmed made up 0.01% of Jefferies Financial Group's portfolio in Q2 2026, its #945 holding.
  • Jefferies Financial Group first reported a position in Insmed in Q1 2023 and has held it in 13 quarters since.
  • Jefferies Financial Group's Insmed position peaked at $161M in Q4 2025.
  • 665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.